US Patent Issued to Diverse Biotech on Oct. 28 for "Platinum complex anti-neoplastic agents comprising a cannabinoid ligand" (Florida Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,711, issued on Oct. 28, was assigned to Diverse Biotech Inc. (Orlando, Fla.).

"Platinum complex anti-neoplastic agents comprising a cannabinoid ligand" was invented by Paul Hershberger (Miami) and Philip Arlen (Miami).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides platinum complex anti-neoplastic agents that comprise at least one cannabinoid ligand as either a leaving ligand or an axial ligand. After the agent enters the cell, the cannabinoid ligand is released as a cannabinoid, where the cannabinoid can then provide additional therapeutic benefits."

The patent was filed on June 24, 2020, under Application No. 17/636,081.

*...